Literature DB >> 15191925

Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs.

Ya-Wen Chen1, Kuo Chu Hwang, Cheng-Chieh Yen, Yih-Loong Lai.   

Abstract

Fullerene derivatives have often been used as effective scavengers for reactive oxygen species (ROS). This study was designed to test whether polyhydroxylated fullerene derivatives [C(60)(OH)(7+/-2)] protect against oxidative stress in cultured RAW 264.7 cells and ischemia-reperfused (IR) lungs. In RAW 264.7 cells, sodium nitroprusside (SNP, 1 mM) and H(2)O(2) (400 microM) caused a marked (90%) decrease in cell viability, and this decrease was dose dependently reversed by pretreatment with C(60)(OH)(7+/-2) (10-50 microM). The increase in ROS production induced by SNP and H(2)O(2) was significantly suppressed by C(60)(OH)(7+/-2). Also, the decrease in mitochondrial membrane potential induced by SNP and H(2)O(2) was significantly reversed by C(60)(OH)(7+/-2). However, high concentration of C(60)(OH)(7+/-2) (1 and 1.5 mM) lead to cell death (apoptosis or necrosis). In the isolated rat lung, the increases in pulmonary artery pressure and capillary filtration pressure induced by SNP during IR were reversed significantly by C(60)(OH)(7+/-2) (10 mg/kg). These results indicate that polyhydroxylated fullerene derivatives C(60)(OH)(7+/-2) at low concentrations protect against oxidative stress in RAW 264.7 cells and IR lungs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191925     DOI: 10.1152/ajpregu.00310.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  20 in total

Review 1.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 2.  Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Authors:  A N Ilinskaya; M A Dobrovolskaia
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 3.  Nanoparticles and direct immunosuppression.

Authors:  Terrika A Ngobili; Michael A Daniele
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

4.  Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.

Authors:  Jie Meng; Dong-liang Wang; Paul C Wang; Lee Jia; Chunying Chen; Xing-Jie Liang
Journal:  J Nanosci Nanotechnol       Date:  2010-12

5.  Cationic fullerenes are effective and selective antimicrobial photosensitizers.

Authors:  George P Tegos; Tatiana N Demidova; Dennisse Arcila-Lopez; Haeryeon Lee; Tim Wharton; Hariprasad Gali; Michael R Hamblin
Journal:  Chem Biol       Date:  2005-10

Review 6.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

7.  Polyhydroxylated fullerene C₆₀(OH)₄₄ suppresses intracellular lipid accumulation together with repression of intracellular superoxide anion radicals and subsequent PPARγ2 expression during spontaneous differentiation of OP9 preadipocytes into adipocytes.

Authors:  Yasukazu Saitoh; Hiromi Mizuno; Li Xiao; Sayuri Hyoudou; Ken Kokubo; Nobuhiko Miwa
Journal:  Mol Cell Biochem       Date:  2012-04-01       Impact factor: 3.396

8.  Effect of fullerenol C(60)(OH) (24) on lipid peroxidation of kidneys, testes and lungs in rats treated with doxorubicine.

Authors:  Ivana Vapa; Vukosava Milic Torres; Aleksandar Djordjevic; Velibor Vasovic; Branislava Srdjenovic; Viktorija Dragojevic Simic; Jovan K Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-04-24       Impact factor: 2.441

9.  Polyhydroxyfullerene binds cadmium ions and alleviates metal-induced oxidative stress in Saccharomyces cerevisiae.

Authors:  Arunava Pradhan; José Paulo Pinheiro; Sahadevan Seena; Cláudia Pascoal; Fernanda Cássio
Journal:  Appl Environ Microbiol       Date:  2014-07-18       Impact factor: 4.792

Review 10.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.